The next frontier in precision medicine and health innovation for preventing and treating inflammation and metabolic disease.
BioTherapeutics, Inc. Announces Publication of Results from Phase 1 Human Clinical Trial of Abscisic Acid in Healthy Volunteers
Accelerating the Path to Cures: New Insights on the Application of Advanced Computational Approaches in Drug Development
Biotherapeutics Inc. (BTI) is a science-based biotechnology company that integrates Nutritionals, Therapeutics and IT to advance interventions for preventing and treating autoimmune and metabolic diseases.See more about us
Interested in becoming a part of the BTI team? Take a look at our job openingsView all positions
NIMML at BTI
NIMML uses innovation to tackle challenges in infectious, immune-mediated, and chronic inflammatory disease research. BTI was founded in 2008 by Dr. Josep Bassaganya-Riera as a result of the technology developed at VT’s Nutritional Immunology and Molecular Medicine Laboratory (NIMML).Go to NIMML Website